Dermatitis Research - Contact-, Seborrheic-, Atopic-, Allergic-Dermatitis, Treatment

Dermatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Dermatitis, including details on contact-, seborrheic-, atopic-, allergic-dermatitis, treatment.


Dermatitis Research Today

Home

View Latest Issue

Information About Dermatitis

Books on Dermatitis

Advertising in Research Today

View Other Research Today Publications



Volume 8 (2011), Issue 4 (April)

  1. Pediatric allergy and immunology in Italy.
    Pediatr Allergy Immunol, 22(3): 267-76. [Abstract] [Full-text]
  2. Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results.
    Pediatr Allergy Immunol, 22(3): 305-12. [Abstract] [Full-text]
  3. Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
    Eur J Pharmacol, 658(2): 263-9. [Abstract] [Full-text]
  4. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
    Am J Clin Dermatol, 12(3): 210-3. [Abstract] [Full-text]
  5. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Am J Clin Dermatol, 12(3): 171-80. [Abstract] [Full-text]
  6. Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga mice.
    J Appl Microbiol, 110(5): 1195-202. [Abstract] [Full-text]
  7. Tetraspanins CD9 and CD81 are molecular partners of trimeric FcɛRI on human antigen-presenting cells.
    Allergy, 66(5): 605-11. [Abstract] [Full-text]
  8. Relationship between type 1 diabetes and atopic diseases in a twin population.
    Allergy, 66(5): 645-7. [Abstract] [Full-text]
  9. Innovative solutions: beds, baths, and bottoms: a quality improvement initiative to standardize use of beds, bathing techniques, and skin care in a general critical-care unit.
    Dimens Crit Care Nurs, 30(3): 169-76. [Abstract] [Full-text]
  10. Skin manifestations of drug allergy.
    Br J Clin Pharmacol, 71(5): 672-83. [Abstract] [Full-text]
  11. Deodorants are the leading cause of allergic contact dermatitis to fragrance ingredients.
    Contact Dermatitis, 64(5): 258-64. [Abstract] [Full-text]
  12. Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis.
    Contact Dermatitis, 64(5): 245-57. [Abstract] [Full-text]
  13. Genetic variations in MyD88 adaptor-like are associated with atopic dermatitis.
    Int J Mol Med, 27(6): 795-801. [Abstract] [Full-text]
  14. Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.
    Pharmacogenet Genomics, 21(5): 303-7. [Abstract] [Full-text]
  15. Fixed drug eruption caused by mefenamic acid: a case series and diagnostic algorithms.
    J Dtsch Dermatol Ges, 9(5): 374-8. [Abstract] [Full-text]
  16. Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic antipiletic drugs.
    Eur J Clin Pharmacol, 67(5): 463-70. [Abstract] [Full-text]
  17. Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.
    J Eur Acad Dermatol Venereol, 25(5): 508-15. [Abstract] [Full-text]
  18. Occupational contact dermatitis: known knowns and known unknowns.
    Clin Dermatol, 29(3): 325-30. [Abstract] [Full-text]
  19. Clinical and experimental aspects of allergic contact dermatitis to para-phenylenediamine.
    Clin Dermatol, 29(3): 316-24. [Abstract] [Full-text]
  20. New and emerging cosmetic allergens.
    Clin Dermatol, 29(3): 311-5. [Abstract] [Full-text]
  21. Sunscreen allergy and its investigation.
    Clin Dermatol, 29(3): 306-10. [Abstract] [Full-text]
  22. Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications.
    Clin Dermatol, 29(3): 295-9. [Abstract] [Full-text]
  23. Effective prescribing in steroid allergy: controversies and cross-reactions.
    Clin Dermatol, 29(3): 287-94. [Abstract] [Full-text]
  24. Recent advances in the management of hand dermatitis: does alitretinoin work?
    Clin Dermatol, 29(3): 273-7. [Abstract] [Full-text]
  25. Extra domain A-positive fibronectin-positive feedback loops and their association with cutaneous inflammatory disease.
    Clin Dermatol, 29(3): 257-65. [Abstract] [Full-text]
  26. Inhibitory effects of UV-based therapy on dry skin-inducible nerve growth in acetone-treated mice.
    J Dermatol Sci, 62(2): 91-7. [Abstract] [Full-text]
  27. The impact of the latest classification system of benign vulvar diseases on the management of women with chronic vulvar pruritus.
    Indian J Dermatol Venereol Leprol, 77(3): 294-9. [Abstract] [Full-text]
  28. Evaluation of hypothalamic-pituitary-adrenal axis in patients with atopic dermatitis.
    Indian J Dermatol Venereol Leprol, 77(3): 288-93. [Abstract] [Full-text]
  29. Cutaneous lepidopterism: dermatitis from contact with moths of Hylesia metabus (Cramer 1775) (Lepidoptera: Saturniidae), the causative agent of caripito itch.
    Int J Dermatol, 50(5): 535-41. [Abstract] [Full-text]
  30. An epidermotypic model of interface dermatitis reveals individual functions of fas ligand and gamma interferon in hypergranulosis, cytoid body formation, and gene expression.
    Am J Dermatopathol, 33(3): 244-50. [Abstract] [Full-text]
  31. Evidence-based skin care management in radiation therapy: clinical update.
    Semin Oncol Nurs, 27(2): e1-17. [Abstract] [Full-text]
  32. Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.
    Am J Pathol, 178(5): 2091-9. [Abstract] [Full-text]
  33. Association of blood mercury concentrations with atopic dermatitis in adults: a population-based study in Korea.
    Environ Res, 111(4): 573-8. [Abstract] [Full-text]
  34. Celiac disease of the joint.
    Rheumatol Int, 31(5): 573-6. [Abstract] [Full-text]
  35. Morbilliform drug eruption due to pegylated α-interferon can show complete regression after switching to non-pegylated interferon.
    J Dermatol, 38(5): 479-81. [Abstract] [Full-text]
  36. Clinical application of static fluorescence-based cytometry, Cellscan, in cutaneous adverse drug reaction.
    J Dermatol, 38(5): 447-55. [Abstract] [Full-text]
  37. The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes.
    Br J Dermatol, 164(5): 996-1003. [Abstract] [Full-text]
  38. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children.
    Br J Dermatol, 164(5): 1078-82. [Abstract] [Full-text]
  39. Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development.
    Scand J Immunol, 73(6): 536-45. [Abstract] [Full-text]
  40. Phospholipase Cɛ has a crucial role in ultraviolet B-induced neutrophil-associated skin inflammation by regulating the expression of CXCL1/KC.
    Lab Invest, 91(5): 711-8. [Abstract] [Full-text]
  41. An important role of lymphatic vessel activation in limiting acute inflammation.
    Blood, 117(17): 4667-78. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2013 Dermatitis Research Today. All Rights Reserved.



Dermatitis Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



Dermatitis Books

Atopic Dermatitis, Second Edition

Atopic Dermatitis, Second Edition